跳转到主要内容


Meet with our product experts in one-on-one virtual sessions

Set Up a Meeting
快速连接

新闻

Dr. Reddy’s Wins Big at “Express Pharma Excellence Awards 2025”

Dr. Reddy’s Wins Big at “Express Pharma Excellence Awards 2025”
Dr. Reddy’s Wins Big at “Express Pharma Excellence Awards 2025”
 

We are thrilled to announce that Dr. Reddy's Laboratories has been honored with multiple accolades at the Express Pharma Excellence Awards 2025. These prestigious awards recognize our excellence in three key categories:

  1. Export Powerhouse (FY24) Finished Formulations: Celebrating our global reach and impact in delivering high-quality finished pharmaceutical products.
  2. Market Trailblazers: Acknowledging our innovative strategies and leadership in the pharmaceutical market.
  3. Export Powerhouse (FY24) APIs & Intermediates: Highlighting our strength in exporting active pharmaceutical ingredients and intermediates worldwide.

These awards are a testament to our unwavering commitment to innovation, quality, and excellence in the pharmaceutical industry. We are incredibly proud of our dedicated team whose hard work and passion have made these achievements possible. Thank you to @Express Pharma for recognizing our efforts and to our partners, customers, and stakeholders for their continuous support. Together, we are making a difference in global healthcare.

Contact Us

请填写以下表格,我们会尽快与您联系.

给我们发电子邮件: api@drreddys.com | +91 40 49002222

免责声明

本目錄中的任何信息(包括對任何產品或服務的任何引用)均不構成銷售要約,或被解釋為代表銷售要約。受有效專利保護的產品不提供或供應用於商業用途。但是,只要存在此類監管豁免,就可以出於監管提交的目的提供此類產品的研究數量。買方應對各自市場的專利方案進行獨立評估,並承擔所有與專利相關的責任。在印度受有效專利保護的產品不可用於商業用途,但可用於第 107A 節。